arrow sskip to content skip to navigation
Datwyler Logo
  • Healthcare
    • Applications
      • Vials
      • Prefilled Syringes
      • Cartridges
      • Blood collection
      • Single-use Syringes
    • Service Offering
      • StarterPack™
      • Packaging & Sterilization
      • Regulatory Support
    • Manufacturing levels
      • FirstLine®
  • Mobility
    • Applications
      • Advanced Technologies
      • Battery Seals
      • Brake Systems
      • Electrified Powertrain
      • Emission Reduction Systems
      • Fuel Cells
      • Vehicle Interior
    • Solution Design
      • Simulation
    • Material Expertise
      • Materials for Electrification
      • Technology & Innovation Labs
    • Operational Excellence
      • O-Rings
      • Liquid Silicone Rubber
      • Global Network
  • Connectors
  • General Industry
    • Services
      • Feasibility Check
    • Markets
      • Energy Generation
      • Drinking Water and Heating
    • Products
    • Offering
  • Food & Beverage
    • Products & Services
      • Form in Place Gaskets
      • Deep Drawing
    • Industrialization Partner
  • Company
    • About us
      • Values
      • History
    • Strategy
      • Sustainability
      • Agility
      • Digitalization
      • Profitable growth
    • Core competencies
      • Solution design
      • Material expertise
      • Operational excellence
    • Innovation
      • Advanced technologies
      • Electro Active Polymers (EAP)
      • Wearable Sensors
    • Governance
      • Board of Directors
      • Executive Management
      • Compliance
      • Shareholder Structure
    • Careers
      • Apprenticeship
      • Pension Fund
Contact Media Supplier Investors Careers Sitemap Search

Datwyler to double capacity at its Indian facility

News | July 26, 2022
Datwyler, a leading manufacturer of system-critical elastomer components for pharmaceutical packaging, will nearly double capacity at its production operation in Pune, India, and add 400 jobs in the near future. By starting up a second plant on the premises in the third quarter 2022, Datwyler will increase output significantly to meet growing global demand.

For some time now, Datwyler has been operating all three production standards at its Indian site: Essential, Advanced and FirstLine®. Examples for the FirstLine® Standard are OmniFlex® stoppers for use in vials for global distribution. FirstLine® is the most advanced manufacturing concept in the industry that is specially designed to manufacture pharmaceutical rubber components for the high-end pharmaceutical and biotech markets. It is designed to meet the highest bar for quality assurance in the production of critical components for pharmaceutical packaging. The operation encompasses ultra-modern cleanroom technology, automated production cells, automated camera inspection, and a unique validated washing process.

We are excited to  start up the second plant at our Pune site in these days and proud to significantly expand our capacity.

Portrait image of Dirk Borghs Dirk Borghs
COO Healthcare Solutions
Doubling of capacity at the Indian plant

The expansion of the Pune facility originally began in 2019, making the original facility Datwyler Healthcare’s largest production operation by volume. Since then, a whole second plant for Essential and Advanced production standard has been added to the campus.  This will enable Datwyler to continuously relocate Essential and Advanced production units from the first plant to the new second plant. As a result, there will be free space in the first plant, which will make it possible to expand production capacity for the FirstLine®standard.

The entire facility incorporates rational and lean production flows in accordance with the Six Sigma methodology. The FirstLine® standard is used to produce Datwyler’s most complex elastomer components. Furthermore, Datwyler’s highly specialized fluoropolymer spray coated components are manufactured exclusively with this standard and FirstLine® is characterized by numerous components to guarantee the highest level of quality and safety.

The impetus for the expansion at the Pune facility comes from the demand generated for critical pharmaceutical packaging components as the injectables market grows rapidly.

Rahul Dev
Senior VP Global Operations Healthcare Solutions

Further information

  • Board iconMedia
    Library
  • Syringe iconHealthcare
    Solutions
  • Group of people iconMore about
    Datwyler

Focus

  • Healthcare Healthcare
Home Media News Doubling of capacity at the Indian plant
Dätwyler Logo
Healthcare Mobility Connectors General Industry Food & Beverage Company
Contact Media Supplier Investors Careers Sitemap Search
© 2023 Dätwyler Holding Inc. All rights reserved.
Privacy Policy Legal notice

Cookie settings

To enjoy the entire content and full feature set of this website and allow us to anonymously track data for statistical and analytical purposes it is necessary to set cookies. It's your choice to allow this. Learn more in our Privacy policy.

Language settings